CXCR3 and inflammatory bowel disease: Its expression drives T cells to atherosclerotic plaques [35] and, in combination with CXCR3, to inflammatory lesions in autoimmune diseases such as rheumatoid arthritis (RA), inflammatory bowel disease (IBD) and multiple sclerosis (MS) [36, 37] (Table 2).